<DOC>
	<DOCNO>NCT01465425</DOCNO>
	<brief_summary>The ACRIN 7151 trial use medical record abstraction data participant extracolonic finding ( ECFs ) report ACRIN 6664 National CT Colonography Trial : 1 ) measure incidence diagnostic imaging , hospitalization , interventional procedure associate ECFs report computed tomography colonography ( CTC ) , delineate type ECF ; 2 ) determine potential predictor follow-up diagnostic imaging , hospitalization , interventional procedure , delineate type ECF ; 3 ) evaluate clinical/pathologic diagnosis associate indeterminate potentially significant ECFs . These data use incorporate ECFs exist model cost-effectiveness CTC colorectal cancer screen potentially use develop guideline report management ECFs .</brief_summary>
	<brief_title>Extracolonic Findings Computed Tomography ( CT ) Colonography</brief_title>
	<detailed_description>The original ACRIN 6664 National CT Colonography Trial include 15 participate site total study data set 2531 participant . The target study data set ACRIN 7151 trial 520 participant , assign one three cohort : E3/E4 Case Group ( n = 141 ) exclude pulmonary nodule , E3/E4 Pulmonary Nodules Case Group ( n = 119 ) , E1 Control Group ( n = 260 ) ( see Section 8.6 ) . Medical record collect site institution primary care provider identify participant ACRIN 6664 trial . Initial record collection comprise six month follow CTC cohort . Additional medical record collection ( primary care provider , specialist , hospital , extend time period ) may necessary primary endpoint determination . ECFs categorize accord original radiology read CTC ACRIN 6664 trial .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Multiple Pulmonary Nodules</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<mesh_term>Solitary Pulmonary Nodule</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Adrenal Gland Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Adnexal Skin Appendage</mesh_term>
	<criteria>No participant subpopulation exclude prior selection ( E1 population match Case Group population ) . Data 15 participate site ACRIN 6664 trial provide study data set 2531 participant , broken total target study data set 520 participant . Participants distribute one three cohort follow : The Case Group target consent 141 participant case indeterminate potentially significant finding ( E3/E4s ) pulmonary nodule . The Pulmonary Nodules Case Group comprise 119 case E3/E4 ECFs characterize pulmonary nodule . The E1 Control Group draw 866 E1 ECF case create cohort 260 E1ECF case . The Control Group comparison Case Group Pulmonary Nodules Case Group select Biostatistics Data Management Center ( BDMC ) . The BDMC match E1 141 control 141 casegroup participant indeterminate potentially significant finding ( E3/E4s ) . The BDMC also match 119 E1 control 119 E3/E4 pulmonary nodule case . Controls match site , age caliper ( 5 year ) , sex possible . Where appropriate match obtain , match criterion relax . If potential participant decline study consent , bestmatch additional case appropriate group maintain target population . Any additional case beyond initial 520 participant identify medical record collection match feasible .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>extracolonic finding</keyword>
	<keyword>ECFs</keyword>
	<keyword>CT colonography</keyword>
	<keyword>compute tomography colonography</keyword>
	<keyword>National CT Colonography Trial</keyword>
	<keyword>ACRIN 6664</keyword>
</DOC>